Ibrutinib was connected with a significantly increased threat of bleeding (general bleeding and main bleeding) in sufferers with B-cell malignancies [RR = 2
Ibrutinib was connected with a significantly increased threat of bleeding (general bleeding and main bleeding) in sufferers with B-cell malignancies [RR = 2.56, 95% CI 1.68C3.90, 0.0001 and RR =…